Treatment of Type 2 Diabetes Flashcards

1
Q

What are the treatment goals for T2DM?

A
  • Reduce microvascular complications eg, retinopathy, nephropathy and foot disease.
  • Reduce macrovascular complications eg, MI, stroke, heart failure, PVD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the biomedical treatment targets for T2DM?

A
  • HbA1c of 7% or 53mmol/mol.
  • BP <130/80,
  • Cholesterol <5
  • Healthy body weight
    These aims depend on age, duration of diabetes, complications, co-morbidities, current lifestyle.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the different class of glucose lowering drugs?

A

Metformin,
- Sulphonylureas,
- Glitazones,
- Insulin,
- DPP-4 inhibitors (gliptins),
- GLP1-receptor agonists (tides)
- SGLT2 inhibitors (flozins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is first, second and third line therapy for T2DM

A

First = Metformin +/- empagliflozin if they have CV risks
Second line = Add sulphonylureas, pioglitazone, DPP-4 inhibitor or SGLT2 inhibitor if HbA1c > 58mmol/l
Third line = Metformin + 2 other second line drugs or metformin + insulin/GLP-1 (both injectables).
Fourth line = Metformin + oral + swap an oral drug for injectible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the glucose lowering drugs preferred for patients who also have CV disease?

A
  • SGLT2 inhibitors or GLP-1 inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the mechanism of metformin and its main side effects

A
  • Suppresses hepatic gluconeogensis (hepatic glucose production) and increases peripheral insulin sensitivity (increasing glucose uptake)
  • Side effects: Lactic acidosis, diarrhoea and abdo pain.
  • Contraindicated if eGFR <30ml/min
  • Does not cause hypoglycaemia but only moderately affective
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name an example of sulphonylureas, its function and side effects

A
  • Gliclazide.
  • Increases stored insulin in beta cells by closing potassium channels. Increases cellular glucose uptake.
  • Side effects include high risk of hypoglycaemia, weight gain and increase CV risk.
    • However these are highly effective

S for Sponge as they squeeze the insulin out of the pancrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Name an example of a DPP-4 inhibitors, the mechanism of action and side effects

A
  • Sitgliptin
  • They inhibit DPP-4 (enzyme which degrades incretins) which enhances effects of endogenous incretins. They also increase insulin secretion and decrease glucagon secretion
  • May cause GI side effects and pancreatitis but few side effects
  • Low risk of hypos

siting on my Dairyair (arse)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name an example of a SGLT2 inhibitor, the mechanism of action and side effects

A
  • Empagliflozin
  • They inhibit the SGLT2 in the proximal convoluted tubule to decrease renal reabsorption of glucose.
  • Side effects include UTIs, DKA or hypovolaemia.
  • Cardiovascular benefit and renal benefit, weight loss and low hypo risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Name an example of a Thiazolidinediones, the mechanism of action and side effects

A
  • Pioglitazone
  • PPAR gamma receptor agonist. Increases sensitivity of fat, muscles and liver to endogenous/exogenous insulin. Decreases liver production of glucose
  • Causes weight gain, fluid retention and fractures so AVOID in heart failure and osteoporosis

NOT IN HEART FAILURE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name an example of a GLP-1 receptor agonist, the mechanism of action and side effects

A
  • Exenatide
  • Mimic function of GLP-1. Increases insulin secretion, decreases glucagon secretion and decreases appetite.
  • Injectable and may have GI side effects but has high efficacy

CV PROTECTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Where are the sites of action for insulin?

A
  • Increases glucose uptake and utilisation in skeletal muscle,
  • reduced hepatic glucouse production
  • decreases lipolysis
  • Decreases gluconeogenesis
  • Side effects are weight gain, injectable and highest hypo risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the prescribing considerations for the elderly?

A
  • Polypharmacy
  • Likely to have reduced eGF|R,
  • Increased liklihood of hypo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the prescribing considerations in renal disease

A
  • Stop metformin when eGFR is below 30ml/min.
  • Caution with sulphonylureas
  • Dose reduction with DDP-4 inhibitors and GLP-1 agonists
  • SGLT2 inhibitors less effective with reduced eGFR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the prescribe considerations in heart failure?

A
  • DO NOT USE Pioglitazone
  • FLozins can improve outcomes in patients with/without diabetes
  • Metformin can be used in CHF but should be withheld in acute attacks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly